Clinical Trials

Can Pyrukynd Redefine Sickle Cell Treatment Despite Setbacks?
Research & Development Can Pyrukynd Redefine Sickle Cell Treatment Despite Setbacks?

I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert with a wealth of experience in research and development, as well as a keen understanding of technological innovation in the industry. Today, we’re diving into the recent developments surrounding Agios Pharmaceuticals and their

Lifordi Secures $112M for Targeted RA Therapy LFD-200
Research & Development Lifordi Secures $112M for Targeted RA Therapy LFD-200

In a groundbreaking development for rheumatoid arthritis treatment, Lifordi Immunotherapeutics, a clinical-stage biotech firm headquartered in Burlington, Massachusetts, has successfully raised $112 million in a funding round led by Sanofi Ventures, with continued support from prominent investors

What Does High-Dose Nusinersen Mean for SMA Treatment?
Research & Development What Does High-Dose Nusinersen Mean for SMA Treatment?

Spinal Muscular Atrophy (SMA), a rare genetic disorder that causes progressive muscle weakness and significant life challenges, has long been a focus of medical research seeking transformative solutions for affected individuals across all ages. A pivotal moment in this journey arrived on November

How Can We Improve Diagnosis of Radiation Brain Injury?
Tech & Innovation How Can We Improve Diagnosis of Radiation Brain Injury?

Diving into the complex world of radiation-induced brain injury (RIBI), we’re thrilled to speak with a leading expert in radiation oncology and neuroimaging. With years of experience in both clinical practice and cutting-edge research, our guest today has dedicated their career to understanding the

Can New Research Combat Drug-Resistant Fungal Infections?
Research & Development Can New Research Combat Drug-Resistant Fungal Infections?

In a world where medical advancements have conquered countless diseases, a silent yet deadly threat looms large—drug-resistant fungal infections are claiming millions of lives each year, often with little public attention. These infections strike hardest at the most vulnerable, such as cancer

Iambic Secures $100M for AI-Driven Cancer Drug Trials
Research & Development Iambic Secures $100M for AI-Driven Cancer Drug Trials

In a groundbreaking moment for the biotechnology sector, San Diego-based startup Iambic has captured the spotlight by raising an impressive $100 million in Series B financing to propel clinical trials of its AI-discovered cancer drugs, marking a significant milestone for the company. This

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later